NCT06688175View on ClinicalTrials.gov

IMRT Combined With Lobaplatin-based CCRT in Nasopharyngeal Carcinoma

PHASE2Enrolling by invitationINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

November 13, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
Nasopharyngeal NeoplasmsElderlyChemotherapy
Interventions
DRUG

IMRT combined with lobaplatin-based concurrent chemotherapy

IMRT combined with two cycles of lobaplatin-based concurrent chemotherapy

Trial Locations (1)

361003

The First Affiliated Hospital of Xiamen University, Xiamen

All Listed Sponsors
lead

The First Affiliated Hospital of Xiamen University

OTHER